Medicine information
उपयोग
METROTREX 7.5 Tablet contains Methotrexate 7.5 mg, a folate-antimetabolite medicine that affects the growth and activity of certain cells. Methotrexate is prescribed for conditions such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, severe psoriasis, and certain cancers. The appropriate dose, dosing frequency, and duration of treatment depend on the medical condition, treatment response, kidney function, and overall health of the patient. Methotrexate is a potent prescription medicine that requires careful medical supervision. Regular monitoring may include blood counts, liver function, kidney function, and other laboratory tests. METROTREX 7.5 should not be started, stopped, or dose-adjusted without advice from a qualified healthcare professional. METROTREX 7.5 is a product of Steris Healthcare and contains Methotrexate 7.5 mg per tablet. The 7.5 mg amount represents the tablet strength and should not be considered a universal dosage recommendation.
कैसे उपयोग करें
Take METROTREX 7.5 exactly as prescribed by your doctor. Swallow the tablet with water and follow the specific dosing schedule given by your healthcare professional. For conditions such as rheumatoid arthritis and psoriasis, methotrexate is commonly prescribed once weekly, although dosing schedules can vary according to the indication. Never take methotrexate more frequently than prescribed. Your doctor may recommend folic acid supplementation and regular laboratory monitoring during treatment. If you accidentally take methotrexate more frequently than prescribed, seek urgent medical attention because an incorrect dosing schedule can cause serious or potentially life-threatening toxicity.
भंडारण
Store METROTREX 7.5 according to the storage instructions provided on the product packaging. Keep the tablets in their original packaging, away from excessive heat, moisture, and direct sunlight. Keep out of reach of children and pets. Do not use the medicine after the expiry date or if the packaging is damaged.
